Key result
Metabolic syndrome affects ~60% to ~69% of an urban Mexican population across standard definitions.
Why the study?
The prevalence of metabolic syndrome components in an urban Mexican population was not well characterized.
Cross-Sectional (n=854)
Absolute Event Rate: 59.7% vs 68.7%
MS prevalence data may guide local screening in Mexico; leaves open outcome associations in longitudinal studies.
Background. The aim of this study was to examine the prevalence of metabolic syndrome (MS) components in an urban Mexican sample. Methods. A total of 854 subjects were included. Anthropometric, blood pressure measurements, clinical data, and overnight fasting blood samples were obtained from all subjects. Results. In accordance with definitions by the American Heart Association/ National Heart, Lung, and Blood Institute (AHA/NHLBI) and the International Diabetes Federation (IDF), the prevalence of MS among participants was 59.7 and 68.7%, respectively. The prevalence of MS was higher in women and in individuals older than 45 years of age. More than 40% of the subjects fulfilled four criterions of MS according to both definitions. Conclusions. There was a high prevalence of MS components in an urban Mexican sample. Therefore, strong strategies had to be developed for early detection of MS and its components to prevent DMT2 and atherothrombotic complications in these patients.
No takes yet. Share an insight, caveat, or question.
Isordia‐Salas et al. (2011) conducted a cross-sectional in Metabolic syndrome (n=854). Urban Mexican residence was evaluated on Prevalence of metabolic syndrome (AHA/NHLBI vs IDF definitions). The prevalence of metabolic syndrome in an urban Mexican sample was 59.7% according to AHA/NHLBI criteria and 68.7% according to IDF criteria.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: